Showing results (51-60 of 158) with videos related to
Sort By:
Pageof 16
British Journal of Clinical Pharmacology|September 29, 2011
The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney diseaseNicola C Edwards, Richard P Steeds, Colin D Chue, et al.Echo Research and Practice|March 29, 2019
Stress echocardiography in coronary artery disease: a practical guideline from the British Society of EchocardiographyRichard P Steeds, Richard Wheeler, Sanjeev Bhattacharyya, et al.Journal of Thoracic Disease|November 13, 2018
Patient screening for early detection of aortic stenosis (AS)-review of current practice and future perspectivesMartin Thoenes, Peter Bramlage, Pepe Zamorano, et al.Heart (British Cardiac Society)|October 25, 2011
Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance studyColin D Chue, Nicola C Edwards, William E Moody, et al.The Journal of Antimicrobial Chemotherapy|March 29, 2014
Staphylococcus aureus bacteraemia in a UK tertiary referral centre: a 'transoesophageal echocardiogram for all' policyElisabeth Holden, Ahmed Bashir, Ira Das, et al.Biomedicines|February 24, 2024
Structural Progression in Patients with Definite and Non-Definite Arrhythmogenic Right Ventricular Cardiomyopathy and Risk of Major Adverse Cardiac EventsAreej Aljehani, Shanat Baig, Tania Kew, et al.Echo Research and Practice|December 6, 2022
A minimum dataset for a Level 1 echocardiogram: a guideline protocol from the British Society of EchocardiographyRakhee Hindocha, David Garry, Nadia Short, et al.Atherosclerosis|February 22, 2012
Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association?William E Moody, Nicola C Edwards, Melanie Madhani, et al.Orphanet Journal of Rare Diseases|June 7, 2020
Prospective cardiovascular magnetic resonance imaging in adults with Alström syndrome: silent progression of diffuse interstitial fibrosisShanat Baig, Rory Dowd, Nicola C Edwards, et al.BMC Endocrine Disorders|November 28, 2018
Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trialShanat Baig, Vishy Veeranna, Shaun Bolton, et al.Pageof 16